Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology, Gastrointestinal), End-User - Forecast 2023-2030
March 14, 2024 13:31 ET
|
Research and Markets
Dublin, March 14, 2024 (GLOBE NEWSWIRE) -- The "Global Preclinical CRO Market by Services (Bioanalysis & DMPK Studies, Toxicology Testing), Application (Cardiovascular Disease, Dermatology,...
Oncology-Based In-Vivo CRO Market Projected for Vigorous Growth, North America Leads Regional Shares
March 07, 2024 12:09 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Oncology-based In-Vivo CRO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Industry Anticipates Major...
Preclinical Assets Market to Surge, Spotlight on Advances in Asia-Pacific
March 07, 2024 12:03 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Preclinical Assets Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global preclinical assets market has...
Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
February 29, 2024 04:06 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Report 2024: Comprehensive Insight on All Drugs in the Clinical Pipeline by Company, Indication & Phase
February 29, 2024 04:05 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Bicycle Toxin Conjugates Clinical Trials & Market Opportunity Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
In Silico Clinical Trials Market Report 2023-2033 - Expanded Therapeutic Areas Present Lucrative Opportunities
February 16, 2024 04:09 ET
|
Research and Markets
Dublin, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering. The in silico clinical trials market...
Global DLL3 Targeted Therapy Market Research Report 2024 - Innovations, Opportunities, Market Trends & Clinical Trials Insights
February 01, 2024 03:16 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global DLL3 Targeted Therapies Market Opportunities & Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. ...
Overview of SAb Biotherapeutics' Drug SAB-176: Phase IIb Trial Insights, SWOT Analysis, and Market Forecast to 2032
January 30, 2024 05:31 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "SAB-176 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers a...
Global Patient-Derived Xenograft/PDX Model Market Set to Expand with Growing Emphasis on Personalized Medicine and Cancer Research
January 30, 2024 05:20 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Patient-Derived Xenograft/PDX Model Market by Type (Mice, Rat), Implantation Method (Subcutaneous, Orthotopic), Tumor Type (Respiratory,...
Analysis of DNAtrix's Drug DNX-2401, 2023 to 2032: A Promising Candidate for Glioblastoma Multiforme (GBM) Treatment
January 30, 2024 05:01 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "DNX-2401 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The pharmaceutical industry...